What we're reading, January 19, 2017: California has withdrawn a request to sell health coverage for illegal immigrants; Pfizer's CEO pushes back against Donald Trump's depiction of the pharmaceutical industry; some Republican governors urge caution on Obamacare repeal.
With Donald J. Trump’s administration poised to enter the White House, California has backed off a request to sell unsubsidized health insurance to illegal immigrants. According to AP, Covered California was notified that the request in to CMS would face a 1-month comment period and a 180-day window for the final decision, which would let the decision fall to Trump’s administration. Currently, immigrants who do not have legal status can buy health coverage through an insurance agent.
One pharmaceutical executive is pushing back against Trump’s depiction of the industry. At the World Economic Forum in Davos, Switzerland, Pfizer’s CEO said pharmaceutical companies are not, as Trump said, “getting away with murder,” according to FiercePharma. Ian Read said the reputation that the pharmaceutical industry has gotten does not represent the ethical part of the industry. He distanced himself from Martin Shkreli, the former CEO of Turing Pharma, as well as Valeant Pharmaceuticals.
Some Republican governors are urging that Republican lawmakers show caution as they work to repeal the Affordable Care Act. Governors who have expanded Medicaid are concerned about the effect of repealing the healthcare law, reported The Wall Street Journal. Ohio Governor John Kasich will join at least 8 other governors and 2 lieutenant governors for a roundtable, Senate Finance Committee Republicans, on the future of Medicaid expansion.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen